Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Study of Sh2d1a Gene Mutation in Paediatric Patients With B-Cell Lymphoma Publisher Pubmed



Koochakzadeh L1 ; Hosseinverdi S1, 2 ; Hedayat M3 ; Farahani F1 ; Tofighi A1 ; Eghbali M1 ; Bidoki AZ4 ; Izadyar M1 ; Rahiminejad MS1 ; Ramyar A1 ; Aghamohammadi A1, 2 ; Rezaei N1, 2, 4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States
  4. 4. Molecular Immunology Research Center, Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Allergologia et Immunopathologia Published:2015


Abstract

Background: X-linked lymphoproliferative disease (XLP) is an often fatal inherited immunodeficiency disorder characterised by fulminant infectious mononucleosis, acquired haemophagocytic lymphohistiocytosis, dysgammaglobulinaemia and malignant lymphoma. Given the paucity of data on the genetic stratification of XLP gene mutations in paediatric patients diagnosed with B-cell lymphoma, we sought to determine the existence of such association in the present study. Methods: We studied 20 male subjects diagnosed with non-Hodgkin B-cell lymphoma. Results: Eleven patients had laboratory evidence of EBV infection by serology and quantitative PCR. The SH2D1A gene analysis was negative in all patients. Conclusions: This is the first study to analyse the SH2D1A gene mutations in Iranian paediatric patients diagnosed with lymphoma. Although we could not demonstrate such an association in our cohort of patients, larger, multi-centre studies are required to extend and confirm our early findings. © 2014 SEICAP.
Related Docs
1. Primary Immunodeficiencies and Cancers, Cancer Immunology: A Translational Medicine Context (2015)
2. Inborn Errors of Immunity and Cancers, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
5. Common Presentations and Diagnostic Approaches, Stiehm's Immune Deficiencies: Inborn Errors of Immunity (2020)
6. Autoimmunity in Primary T-Cell Immunodeficiencies, Expert Review of Clinical Immunology (2016)
Experts (# of related papers)